Research results to be presented at CTAD Oct. 24-27
Cytox, in collaboration with Cardiff University, University of Birmingham and other leading research partners, is presenting a poster at the 11th Clinical Trials in Alzheimer’s Disease meeting in Barcelona, Spain, October 24-27.
The poster, P127, ‘The Application of Polygenic Risk Score Analysis to Stratification of Subjects for Clinical Trials in Alzheimer’s Disease in Carriers and Non-carriers of the ApoE4 Risk Allele’ is being displayed as part of the Theme 4. Clinical trials: Biomarkers including plasma session at the PALAU DE CONGRESSOS DE CATALUNYA in Barcelona, Spain. It presents the results from collaborative studies carried out by the MRC-Centre for Neuropsychiatric Genetics and Genomics, Cardiff, UK, Birmingham University, the Institute of Neurology, University College London, UK, Cytox Ltd, Oxford, UK, Edith Cowan University and Cooperative research Centre for Mental Health, Perth, Australia and the Dementia Research Institute at Cardiff, UK.
Highlights of the presentation include:
Please view poster here.